{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:56:16Z","timestamp":1794434176362,"version":"4.9.1"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:00:00Z","timestamp":1794268800000},"content-version":"am","delay-in-days":344,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.clinbiochem.2025.111032","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T14:51:06Z","timestamp":1761403866000},"page":"111032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Determining the detection of 216 fentanyl analogs and synthetic opioids and predicting epitopes using four commercial immunoassays"],"prefix":"10.1016","volume":"140","author":[{"given":"Carl E.","family":"Wolf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix I","family":"Medrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin L.","family":"Poklis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Jannetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1879-6249","authenticated-orcid":false,"given":"Grace R.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clinbiochem.2025.111032_b0005","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Curr. Opin. Psychiatry"},{"issue":"Pt A","key":"10.1016\/j.clinbiochem.2025.111032_b0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuropharm.2017.10.016","article-title":"Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review","volume":"134","author":"Armenian","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.clinbiochem.2025.111032_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104417","article-title":"National and regional trends in fentanyl seizures in the United States, 2017-2023","volume":"138","author":"Palamar","year":"2025","journal-title":"Int. J. Drug Policy"},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.111032_b0020","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/add.14474","article-title":"Illicit fentanyls in the opioid street market: desired or imposed?","volume":"114","author":"Mars","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.clinbiochem.2025.111032_b0025","unstructured":"Drug Enforcement Administration, NFLIS-Drug Brief: Substances Co-Reported with Fentanyl in NFLIS-Drug and DEA-Tox, January 2013\u2013June 2023, Diversion Control Division, Editor. 2023."},{"issue":"4","key":"10.1016\/j.clinbiochem.2025.111032_b0030","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/00952990.2022.2081923","article-title":"Trends in characteristics of fentanyl-related poisonings in the United States, 2015-2021","volume":"48","author":"Palamar","year":"2022","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.clinbiochem.2025.111032_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109398","article-title":"Trends in seizures of powders and pills containing illicit fentanyl in the United States, 2018 through 2021","volume":"234","author":"Palamar","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.clinbiochem.2025.111032_b0040","unstructured":"Centers for Disease Control, U.S. Overdose Deaths Decrease Almost 27% in 2024. 2025."},{"key":"10.1016\/j.clinbiochem.2025.111032_b0045","unstructured":"Drug Enforcement Administration, 2018 National Drug Threat Asessment 2018."},{"key":"10.1016\/j.clinbiochem.2025.111032_b0050","unstructured":"Drug Enforcement Administration National Drug Threat Assessment U.S.D.o. Justice, Editor. 2025."},{"key":"10.1016\/j.clinbiochem.2025.111032_b0055","doi-asserted-by":"crossref","unstructured":"Mojica MA, C.M., Isenberg SL, Pirkle JL, Hamelin EI, Shaner RL, Seymour C, Sheppard CI, Baldwin GT, Johnson RC. , Designing traceable opioid material\u00a7 kits to improve laboratory testing during the U.S. opioid overdose crisis. Toxicol Lett. , 2019(317): p. 53-58.","DOI":"10.1016\/j.toxlet.2019.09.017"},{"key":"10.1016\/j.clinbiochem.2025.111032_b0060","doi-asserted-by":"crossref","unstructured":"OH., D., Fatalities caused by novel opioids: a review. Forensic Sci Res., 2018. 4(2).","DOI":"10.1080\/20961790.2018.1460063"},{"key":"10.1016\/j.clinbiochem.2025.111032_b0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.clinbiochem.2023.01.001","article-title":"Detection of 58 fentanyl analogs using ARK fentanyl II and Immunalysis fentanyl immunoassays","volume":"113","author":"Williams","year":"2023","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2025.111032_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmsacl.2022.07.005","article-title":"Development and application of a High-Resolution mass spectrometry method for the detection of fentanyl analogs in urine and serum","volume":"26","author":"Zhang","year":"2022","journal-title":"J. Mass Spectrom. Adv. Clin. Lab."},{"key":"10.1016\/j.clinbiochem.2025.111032_b0075","unstructured":"ARK Diagnostics Inc., ARK Fentanyl Assay Package Insert. 2018."},{"key":"10.1016\/j.clinbiochem.2025.111032_b0080","unstructured":"ARK Diagnostics Inc., ARK Fentanyl II Assay Package Insert. 2020."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912025001614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912025001614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T09:42:17Z","timestamp":1783158137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912025001614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":16,"alternative-id":["S0009912025001614"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.111032","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determining the detection of 216 fentanyl analogs and synthetic opioids and predicting epitopes using four commercial immunoassays","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.111032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.","name":"copyright","label":"Copyright"}],"article-number":"111032"}}